内容へ

血液内科

止血の管理と最適化

遺伝子組換え活性型血液凝固第Ⅶ因子製剤(rFVIIa)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (新しいタブで開く)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

出典‎: Am J Hematol 2002;69(3):219-22.

インデックス‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (新しいタブで開く)